Browsing by Author Malik, Laeeq

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 13 of 13
PreviewIssue DateTitle / NameAuthor(s)Type
2020Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2+/HR+ metastatic breast cancerLoft, Matthew; Lok, Sheau Wen; De Boer, Richard H.; Malik, Laeeq; Greenberg, Sally, et alJournal Article 
Jan-2023Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2 + /HR + metastatic breast cancerLoft, Matthew; Lok, Sheau Wen; De Boer, Richard; Malik, Laeeq; Greenberg, Sally, et alJournal Article 
2018Cardiotoxicity in advanced HER2 positive breast cancer in real world Australian patients receiving HER2-targeted therapy in the first-line settingConduit, C.; King, Rossa; De Boer, Richard; Gibbs, Peter; Lok, Sheau Wen, et alConference Paper 
Nov-2020Impact of prior (neo)adjuvant trastuzumab (NAT) exposure on the efficacy of HER2-targeted therapy for metastatic breast cancerCollins, Ian M.; Kanjanapan, Yada; Wen Lok, Sheau; Gibbs, Peter; De Boer, Richard, et alJournal Article 
2018Management of brainmetastases in patients with HER2 positive breast cancer-a real world Australian experienceMoldovan, Cristina A.; King, Rossa; Lok, Sheau Wen; De Boer, Richard; Gibbs, Peter, et alConference Paper 
2020Real world outcomes in elderly patients with HER2 positive advanced breast cancerEvans, Nicole; Anton, Angelyn; Wong, Rachel; Lok, Sheau Wen; De Boer, Richard, et alConference Paper 
2021Real world outcomes in elderly women with HER2 positive advanced breast cancerEvans, Nicole; Anton, Angelyn; Wong, Rachel; Lok, Sheau Wen; De Boer, Richard, et alConference Paper 
Annals of Oncology - 2020 - Real World Outcomes in Elderly Women with HER2-Positive Advanced Breast Cancer.pdf.jpg2020Real World Outcomes in Elderly Women with HER2-Positive Advanced Breast CancerEvans, Nicole; Anton, Angelyn; Wong, Rachel; Lok, Sheau Wen; De Boer, Richard, et alConference Paper 
2020Real-world impact of anti-HER2 therapy-related cardiotoxicity in patients with advanced HER2-positive breast cancerConduit, C.; de Boer, R. H.; Lok, S.; Gibbs, Peter; Malik, Laeeq, et alJournal Article 
2021Real-world outcomes in patients with brain metastases secondary to HER2-positive breast cancer: An Australian multi-centre registry-based studyTung, Iris; Moldovan, Cristina; Wong, Vanessa; De Boer, Richard; Gibbs, Peter, et alConference Paper 
Oct-2022Real-World Outcomes in Patients With Brain Metastases Secondary to HER2-Positive Breast Cancer: An Australian Multi-centre Registry-based StudyTung, Iris; Moldovan, Cristina; Wong, Vanessa; De Boer, Richard; Yeo, Belinda, et alJournal Article 
2020Real-world uptake of bone modifying agents in advanced breast cancer with bone metastases-Prospective data from a multi-site Australian registryWong, Vanessa; De Boer, Richard; Anton, Angelyn; Malik, Laeeq; Greenberg, Sally, et alConference Paper 
2021Uptake of bone-modifying agents in patients with HER2+ metastatic breast cancer with bone metastases - prospective data from a multi-site Australian registryWong, Vanessa; de Boer, Richard; Dunn, Catherine; Anton, Angelyn; Malik, Laeeq, et alJournal Article